5:30 PM ET
Earnings Call
▶ Call
Niagen Bioscience Earnings Call: Key Takeaways
Niagen Bioscience is navigating a transitional 2026 investment year, focusing on new salt forms and pharmaceutical pipelines to offset current revenue declines and ingredient pricing pressure.
- Call
- Nov 4, 2026, 4:30 PM ET